Why buy Humog Inj. – 150 i.u?
Humog Inj. – 150 i.u is a treatment of choice for induction of ovulation for those with hypothalamic hypogonadism. Hypogonadotropic hypogonadism is a condition where the female ovaries produce little or no sex hormone at all. It is also used in conjunction with HCG for the stimulation of sperms in male with such condition. The active ingredient is approved by FDA for the induction of ovulation and pregnancy in infertile patients. Humog Inj. – 150 i.u is available here. You can buy this hormone here at a very reasonable amount.
How does Humog Inj. – 150 i.u work?
Humog Inj. – 150 i.u contains human menopausal gonadotropin (hMG) hormone. The hormone stimulates the development of the ovaries in order to produce egg cells. When the brain does not release LH and FSH, these hormones will stimulate the production of egg enabling women to reproduce.
How to use Humog Inj. – 150 i.u?
Humog Inj. – 150 i.u is intended for intramuscular injection. It must not be injected into the fat. Use Humog Inj. – 75 i.u once a day or as instructed by your physician. Your doctor will determine your dose depending on your condition. Your dose may also vary from other women and from cycle to cycle. The usual dose, however, is between 75 and 450 IU/day. If you are administering the injection all by yourself, ask for the detailed instructions form your doctor on how to mix and how to administer.
What are the side effects of Humog Inj. – 150 i.u?
Humog Inj. – 150 i.u may cause some undesirable side effects just like any other medications. Some of the side effects are:
- Breathing trouble
- Stomach pain
- Skin rash
- An enlarged ovaries
- Burning sensation
- Redness on the injection site
- Inflammation on the injection site
Warnings and Precautions
Things to remember when using Humog Inj. – 150 i.u:
- Do not use Humog Inj. – 150 i.u if you have:
- Absence of uterus
- Premature menopause
- Tubular occlusion
- Ovarian Dysgenesis
- Adrenocortical deficiency
- Primary testicular failure
- Vaginal bleeding
- Ovarian cyst
- Hormone-related cancer